Variety Of Impacts COVID-19 Poses For Biopharma Reflected In Earnings Calls

 
• By Joseph Haas

Several firms reporting quarterly earnings this week discussed how the outbreak is affecting supply chains, drug launches and clinical trials.

Business people looking at screen during video conference in office
Recent biopharma earnings calls have detailed varying impacts of the coronavirus pandemic

More from COVID-19

More from Scrip